Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Microchip Shares Gain Momentum on Upbeat Forecast

Andreas Sommer by Andreas Sommer
January 16, 2026
in Analysis, Earnings, Semiconductors, Tech & Software
0
Microchip Stock
0
SHARES
11
VIEWS
Share on FacebookShare on Twitter

A positive business update and a series of analyst upgrades have provided a significant boost to Microchip Technology’s stock, driving notable after-hours gains. The semiconductor company now anticipates fiscal third-quarter 2026 revenue of approximately $1.185 billion and has reported key advancements in product qualifications. Whether this marks the start of a sustained recovery will largely depend on the upcoming quarterly results and the state of its order book.

  • Preliminary Q3 Revenue Forecast (Period ending Dec. 31, 2025): ~$1.185 billion
  • Market Reaction: Shares advanced 10.1% on January 6 following the pre-announcement
  • Earnings Report Date: Scheduled for February 5

Analyst Sentiment Turns Positive

The upward move was triggered by Microchip’s January 5 announcement, where it guided for net sales around $1.185 billion for its fiscal Q3. This figure surpassed its previous guidance range of $1.109–$1.149 billion, suggesting a broad-based recovery across its end markets. The subsequent trading session saw the equity climb 10.1%.

In response, several research firms revised their price targets upward, reinforcing the constructive market view. Stifel raised its target to $90 from $80, maintaining a Buy rating. Wolfe Research increased its target to $90 from $76, while Piper Sandler moved to $85 from $80 with an Overweight rating. B. Riley set a new target of $95, up from $85, and Needham adjusted its target to $77 from $75. These adjustments reflect optimism, though the magnitude of the increases varies.

Strategic Progress and Product Milestones

Alongside the financial preview, Microchip announced several technical achievements. On January 15, the company, alongside SST and UMC, completed qualification and production release for its Embedded SuperFlash Gen 4 (ESF4) memory on UMC’s 28HPC+ platform, meeting Automotive Grade 1 standards for vehicle controllers.

Should investors sell immediately? Or is it worth buying Microchip?

Earlier in the month, on January 13, Microchip introduced its JANPTX series of non-hermetic TVS components, which it states are the first of their kind to achieve MIL-PRF-19500 qualification for aerospace and defense applications. Furthermore, on January 8, the firm released custom firmware for NVIDIA DGX Spark AI systems, designed to enhance system management for AI workloads using its MEC1723 embedded controller.

CEO Steve Sanghi attributed the improved outlook to an easing inventory situation, progress on the company’s “nine-point recovery plan,” and plans to ramp up production in the March quarter. Microchip also cited a significant reduction in internal inventories as a component of its recovery trajectory.

Upcoming Catalyst: The Full Quarterly Report

All eyes are now on the official fiscal third-quarter results, set for release on February 5. Confirmation of the preliminary revenue figure and evidence of sustained order growth would likely support the current positive sentiment. Conversely, should the final numbers fall short of the preview or indicate a weaker backlog, the stock could face near-term pressure. The analyst consensus remains broadly favorable, with an average rating of “Moderate Buy” based on 24 ratings, as the share price trades near its 52-week high of $77.20.

Ad

Microchip Stock: Buy or Sell?! New Microchip Analysis from February 7 delivers the answer:

The latest Microchip figures speak for themselves: Urgent action needed for Microchip investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Microchip: Buy or sell? Read more here...

Tags: Microchip
Andreas Sommer

Andreas Sommer

About Andreas Sommer Over 40 years of expertise in market analysis, chart technical analysis, and strategic investment advisory. With more than four decades of experience in banking and financial journalism, Andreas Sommer is recognized as one of the leading analysts in the German-speaking market. His deep understanding of market dynamics and technical analysis has helped countless investors navigate complex financial markets.
Areas of Expertise:
  • Technical Chart Analysis
  • Strategic Investment Advisory
  • Market Trend Analysis
  • Financial Journalism
Andreas brings unparalleled insights from his extensive career in banking and financial markets, making him a trusted voice for investors seeking professional guidance.

Related Posts

Boston Omaha Stock
Analysis

Investors Await March Report for Boston Omaha’s Strategic Direction

February 7, 2026
Universal Insurance Stock
Analysis

Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds

February 7, 2026
Embecta Stock
Earnings

Embecta’s Q1 Performance Outpaces Analyst Forecasts

February 7, 2026
Next Post
DeFi Technologies Stock

Legal Challenges Mount for DeFi Technologies Shareholders

Voestalpine Stock

Voestalpine Shares Slip Despite Securing Historic Contract

BYD Stock

Strategic Partnerships and Policy Shifts Propel BYD Forward

Recommended

XRP Stock

XRP Faces Resistance as Rally Attempt Falters

2 months ago
Insurance company Stock Bull Market

Analyst Expresses Optimism Towards Travelers Companies and Allstate

2 years ago
Rheinmetall Stock

German Defense Giant Rheinmetall Poised for Major Air Defense Contract

4 months ago
Finance_Capitalistic

Top Stock Picks and Performance Analysis on CNBCs Halftime Report Final Trades

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Camping World’s New Leadership Faces First Major Test

Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

Diginex Enters Critical Implementation Phase Following Strategic Moves

Deluxe Stock Gains Momentum on Successful Fintech Transition

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

Trending

Boston Omaha Stock
Analysis

Investors Await March Report for Boston Omaha’s Strategic Direction

by SiterGedge
February 7, 2026
0

With no recent corporate announcements influencing its share price, market attention has shifted decisively to the upcoming...

Universal Insurance Stock

Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds

February 7, 2026
Embecta Stock

Embecta’s Q1 Performance Outpaces Analyst Forecasts

February 7, 2026
Camping World Stock

Camping World’s New Leadership Faces First Major Test

February 7, 2026
Viking Therapeutics Stock

Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Investors Await March Report for Boston Omaha’s Strategic Direction
  • Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds
  • Embecta’s Q1 Performance Outpaces Analyst Forecasts

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com